Amgen Inc (AMGN) — Who Owns This Stock? 13F Breakdown (Q2 2026)

Amgen filed this 8-K on August 4, 2026, to furnish its second-quarter 2026 earnings press release under Items 2.02 and 9.01. The release covers results for the three and six months ended June 30, 2026 and includes both GAAP numbers and non-GAAP measures such as adjusted EPS, operating income, operating margin, tax rate, and expense line items, plus a reconciliation to GAAP and free cash flow. The excerpt doesn't include the actual revenue or profit figures, so we can't tell from this filing alone whether the quarter beat or missed.

Amgen disclosed a cybersecurity incident in July 2026 after spotting unauthorized activity in cloud environments run by third-party providers. The company activated its response plan, brought in independent forensic experts, and confirmed that some data — including proprietary information and patient protected health information — was exfiltrated. So far, it says there's been no impact on its products, manufacturing, financial reporting systems, or ability to meet patient needs. Amgen determined the incident was material for disclosure purposes on July 29, but also said it doesn't currently believe the breach is reasonably likely to have a material impact on its financial condition or results of operations. The investigation is ongoing, and the company says it will amend the 8-K if more required information becomes available.